Biohit to offer Greeks a nicotine-free way to butt out
Biohit has announced the signing of a three-year distribution agreement for its nicotine-free smoking cessation product, Acetium lozenge, in Greece.
Neighbourly development for Helsinki University
The University of Helsinki is collaborating closely with other universities in the region on the development of new pharmaceutical methods and products.
Askel Healthcare takes steps towards healthier pets
This Finnish health startup has discovered the fountain of youth – at least for worn out joints. Fuelled by a passion for animals, its cartilage repair innovation, initially designed for humans, is now making its way to slightly furrier markets.
FIMM and Labcyte expand collaboration
The Institute for Molecular Medicine Finland (FIMM) has extended its collaboration with biotechnology tools company Labcyte, with multiple new approaches to personalised medicine that leverage Labcyte’s acoustic liquid handling technology.
BC Platforms serves as medium for MS research
Finnish BC Platforms offers its technology solutions and research platform to Biogen and the Accelerated Cure Project (ACP) to advance research into multiple sclerosis (MS).
Finnish scientists awarded for dog gel paper
A research group led by Finnish Orion Pharma scientists have landed an award for a study paper on dexmedetomidine oromucosal gel for noise anxiety in dogs.
Biohit secures important patent in Japan
Finnish biotechnology company Biohit has been granted a patent for its Biohit Acetium Capsule in Japan. The Biohit Acetium Capsule binds acetaldehyde in the stomach and is used to treat acid-free stomach and those at risk of obtaining gastric cancer.
Biohit helps China quit smoking
Biohit and Chinese Chinmax Medical Systems have confirmed an agreement for the distribution of the Acetium lozenge in China.
Finnish professor wins German science award
Professor Bjarne Udd has been honoured with the German Duchenne-Erb-Preis science award for his extensive research into neuromuscular diseases.
Finnish stroke treatment settles in Russia
The internationally awarded stroke treatment of the Hospital District of Helsinki and Uusimaa (HUS) gains attention in Russia.
Drug developed in Turku blocks a notorious cancer driver
A research group at the Turku Centre for Biotechnology has found a novel way to inhibit a particularly vicious activity of one of the most notorious cancer drivers: the oncoprotein Ras.